About the Gold Corporate Council Members
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has nearly 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.
BD has partnered with the Gold Foundation on multiple initiatives, including the Gold Human InSight Webinar “A Blueprint for Social Factors that Impact Health: Lessons from Community Health Centers” and the creation of the BD Gold Humanism in Community Health Innovator Award. The inaugural recipient was Ms. Malvise A. Scott, Executive Advisor to the CEO, National Association of Community Health Centers and an iconic leader in the community health field. She received the award in 2019. And in 2021, the award was presented to Thomas Tighe, President and CEO of Direct Relief for his visionary leadership.
For more information on BD, please visit bd.com.
ABOUT CVS HEALTH
CVS Health is the nation’s premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about CVS Health, please visit https://www.cvshealth.com.
ABOUT HENRY SCHEIN, INC.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries. The Company’s sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.
For more information, visit Henry Schein at: www.henryschein.com, Facebook.com/HenrySchein and @HenrySchein on Twitter.
ABOUT IBM WATSON HEALTH
In April 2015, IBM launched the Watson Health business unit to help doctors, researchers, drug and device makers and other healthcare stakeholders accelerate innovation, deepen expertise and expand their knowledge base by surfacing insights from the massive amount of clinical, scientific, genetic and personal health data being created and shared daily. The Watson Health portfolio offers a growing number of offerings across five key health market segments and is successfully working with businesses, health systems and governments worldwide to help solve pressing healthcare challenges and scale the use of cognitive computing technology across developing regions and mature markets. For more information on IBM Watson Health, visit: ibm.com/watsonhealth/.
ABOUT QUEST DIAGNOSTICS
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
Quest Diagnostics has adapted the Gold Foundation’s Tell Me More® communication tool for its Everyday Excellence Program. Tell Me More® encourages connection at the human level and was originally created as a way to patients and clinicians to connect more easily. Watch a video from Quest Diagnostics and Gold Foundation leaders explaining how the employees are utilizing Tell Me More®.
For more information, please visit www.QuestDiagnostics.com.
ABOUT SIEMENS HEALTHINEERS
Siemens Healthineers is a leading medical technology company with over 120 years of experience and 18,500 patents globally. Each day, an estimated 5 million patients globally benefit from its innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. For more information, please visit https://www.siemens-healthineers.com/.
Read the 2017 announcement of the Gold Corporate Council’s formation and its aspiration statement.